Experimental models of the oncogenic potential of double‐PIK3CA mutations7, 8 have shown that these mutations rarely co‐occur with other major oncogenes and tumor suppressors, suggesting a distinct pathway for tumorigenesis; thus, we propose a continuum model in which varying oncogene dosages impact cancer development differently.12 The gene discussed is PIK3CA; the disease is cancer.